Abstract: An apparatus includes an FFE circuit, including a clock generator creating multiple sub-rate phases of an input clock, and a multi-phase sampler responsive to a data signal and to the multiple sub-rate phases generated by the clock generator. The sampler is configured to sample the data signal and to generate held sample outputs corresponding to the multiple sub-rate phases. A SC equalization circuit in the FFE circuit has two states and is responsive to inputs from the multi-phase sampler output and the clock generator. The SC equalization circuit is configured to form outputs using the two states. A variable gain output stage in the FFE circuit is responsive to the outputs from the SC equalization circuit and is responsive to gain control signal(s) to provide variable gains to corresponding outputs of the SC equalization circuit to form equalized outputs based on the data signal.

Abstract: Polyoxazoline-containing compositions cured in the presence of an onium salt catalyst are disclosed.

Abstract: A technology for job processing using a public service network. A method may include identifying processing availability at a public service network for processing a job submitted to a private service network. Available network bandwidth may be determined between the private service network and the public service network used to communicate between the private service network and the public service network and to transfer the job to the public service network for processing. Rules for transferring the job to the public service network may be identified. A determination may then be made that the processing availability at the public service network, the available network bandwidth between the private service network and the public service network, and the rules for transferring the job to the public service network allow the job to be transferred to the public service network for processing.

Abstract: A single-ended inter-chip data transmission system and a single-ended inter-chip data reception system are provided for processing data. A controlled Hamming weight parallel data encoder at a transmitter device accepts N data bits with an arbitrary Hamming weight as input and generates M data bits with a controlled Hamming weight as output, wherein M is greater than N. A transmission circuit provides a time-aligned transmission of the controlled Hamming weight encoded data across a single-ended data bus.

Abstract: The present invention relates to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.

Abstract: A contact location identification apparatus and method consists of a marking device with a first side and a second side. An attachment device is connected with the first side, where the attachment device removably attaches to an object. A marking receptor surface is provided on the second side, where the marking receptor surface holds a transferable marker substance.

Abstract: Devices, systems, and methods that can facilitate in situ probing of a discrete time circuit components are provided. According to an embodiment, a device can comprise a hold circuit that can generate a sampled signal at a holding stage. The device can further comprise an in situ probe device that can be coupled to the hold circuit that can measure one or more operating voltage values at the holding stage based on the sampled signal.

Abstract: A device can comprise a peaked integrator circuit that generates an output signal from a continuous time signal based on a sub rate clock timing cycle. The device can further comprise a track and hold circuit coupled to the output of the peaked integrator that generates a held discrete time signal from the output of the peaked integrator based on a second sub rate clock timing cycle that is offset in time from the sub rate clock timing cycle by a single time unit interval. The device can further comprise an integrator circuit coupled to an output of the track and hold circuit that integrates the held discrete time signal, based on the second sub rate clock timing cycle that is offset in time from the sub rate clock timing cycle by a single time unit interval.

Abstract: The present invention relates to a porcine parvovirus and porcine reproductive and respiratory syndrome virus vaccine for protecting a subject, preferably swine, against diseases associated with porcine parvovirus and porcine reproductive and respiratory syndrome virus. The present invention further relates to methods of producing immunogenic compositions as well as such immunogenic compositions exhibiting reduced virucidal activity.

Abstract: The present invention relates to a substrate having (a) a first material applied to at least a portion of the substrate, and (b) a coating layer deposited from a powder coating composition including a film-forming resin, and optionally a crosslinker that is reactive with the film-forming resin, in direct contact with at least a portion of the substrate to which the first material has been applied. The first material is (i) a catalyst that catalyzes cure of the powder coating composition, (ii) a component reactive with the film-forming resin and/or the crosslinker of the powder coating composition, and/or (iii) a rheology modifier.

Abstract: The present invention relates to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.

Abstract: The present disclosure provides methods and compositions for inhibiting degradation of dimethyl trisulfide (DMTS) in solution. Concentrate compositions include DMTS and polar inorganic or organic solvent. The compositions can be stored in containers for at least 2 weeks at 54° C. or at least one year at room temperature and less than 50% of the DMTS degrades. The concentrate compositions can be diluted for use and combined with other components to form various solutions.

Abstract: The present invention relates to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.

Abstract: Polyoxazoline-containing compositions cured in the presence of an onium salt catalyst are disclosed.

Abstract: A technology for job processing using a public service network. A method may include identifying processing availability at a public service network for processing a job submitted to a private service network. Available network bandwidth may be determined between the private service network and the public service network used to communicate between the private service network and the public service network and to transfer the job to the public service network for processing. Rules for transferring the job to the public service network may be identified. A determination may then be made that the processing availability at the public service network, the available network bandwidth between the private service network and the public service network, and the rules for transferring the job to the public service network allow the job to be transferred to the public service network for processing.

Abstract: The present invention relates to a porcine parvovirus and porcine reproductive and respiratory syndrome virus vaccine for protecting a subject, preferably swine, against diseases associated with porcine parvovirus and porcine reproductive and respiratory syndrome virus. The present invention further relates to methods of producing immunogenic compositions as well as such immunogenic compositions exhibiting reduced virucidal activity.

Abstract: The present invention relates to a porcine parvovirus (PPV) viral protein 2 (VP2) having at amino acid position 228 a glutamic acid residue or a glutamate residue, and/or at amino acid position 414 a serine residue, and/or at amino acid position 419 a glutamine residue, and/or at amino acid position 436 a threonine residue. Further, the present invention relates to immunogenic compositions comprising said PPV viral protein 2 (VP2). Furthermore, the present invention relates to methods for immunizing a subject comprising administering to such subject the immunogenic composition of the present invention. Moreover, the present invention relates to methods of treating or preventing clinical signs caused by PPV infection in a subject of need, the method comprising administering to the subject a therapeutically effective amount of an immunogenic composition according to the present invention.

Abstract: Technology for provision and use of inter service network communication optimization is provided. A method may include determining an available network bandwidth between a private service network and a public service network and determining processing availability at the private service network and at the public service network. Rules may be identified for transferring data between the private service network and the public service network. A determination of whether to transfer data between the private service network and public service network may be made based on the available network bandwidth, the processor availability and the bandwidth rules.

Abstract: A cart has a frame having a pair of elongate side frame members and a cargo-supporting framework having a plurality of supporting ribs, each supporting rib being connected to and extending approximately downward from one side frame member, and a horizontal support structure interconnecting the plurality of supporting ribs. The cart may include at least one of 1) a rigid support member resting on and supported by the horizontal support structure, 2) a containment pan connected to and suspended under the cargo-supporting framework, and 3) a foldable trailer hitch connected to the cart and configured to permit towing of the cart by a vehicle. At least one of the side frame members and the containment pan may include openings, sleeves, or stepped portions configured to receive forks of a forklift to permit lifting of the cart by the forklift, even when loaded.

Abstract: A curable coating composition includes: (a) a binder having a film-forming resin with at least two functional groups, and (ii) a curing agent reactive with the functional groups of the film-forming resin; and (b) solid vulcanized rubber particles that are unreactive with the binder. The curable coating composition is a solid particulate powder coating composition. Multi-layer coating systems and methods of preparing the curable coating composition are also included.